184 related articles for article (PubMed ID: 32304351)
1. Impact of Traumatic Brain Injury on Clinical Institute Withdrawal Assessment Use in Trauma Patients: A Descriptive Study.
Carter W; Truong P; Sima AP; Hupe J; Newman J; Ebadi A
PM R; 2021 Feb; 13(2):159-165. PubMed ID: 32304351
[TBL] [Abstract][Full Text] [Related]
2. Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome.
McCullough MA; Miller PR; Martin T; Rebo KA; Stettler GR; Martin RS; Cantley M; Shilling EH; Hoth JJ; Nunn AM
J Trauma Acute Care Surg; 2024 Mar; 96(3):394-399. PubMed ID: 37934662
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
[TBL] [Abstract][Full Text] [Related]
4. Early recovery following traumatic brain injury and alcohol withdrawal management.
Klyce DW; Graham KM; Lacey RW; Carter WE
Rehabil Psychol; 2018 Nov; 63(4):588-594. PubMed ID: 30211607
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
[No Abstract] [Full Text] [Related]
7. "Should We Phenobarb-it-All?" A Phenobarbital-Based Protocol for Non-Intensive Care Unit Trauma Patients at High Risk of or Experiencing Alcohol Withdrawal.
Wang M; Falank C; Simboli V; Ontengco JB; Spurling B; Rappold J; Chung B; Smith KE
Am Surg; 2024 Jun; 90(6):1531-1539. PubMed ID: 38574377
[TBL] [Abstract][Full Text] [Related]
8. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
[No Abstract] [Full Text] [Related]
9. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
Woods AD; Giometti R; Weeks SM
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
[TBL] [Abstract][Full Text] [Related]
10. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
[TBL] [Abstract][Full Text] [Related]
11. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
[TBL] [Abstract][Full Text] [Related]
12. Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?
Steel TL; Giovanni SP; Katsandres SC; Cohen SM; Stephenson KB; Murray B; Sobeck H; Hough CL; Bradley KA; Williams EC
Addict Sci Clin Pract; 2021 Mar; 16(1):21. PubMed ID: 33762020
[TBL] [Abstract][Full Text] [Related]
13. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
[TBL] [Abstract][Full Text] [Related]
14. Occurrence, Predictors, and Prognosis of Alcohol Withdrawal Syndrome and Delirium Tremens Following Traumatic Injury.
Salottolo K; McGuire E; Mains CW; van Doorn EC; Bar-Or D
Crit Care Med; 2017 May; 45(5):867-874. PubMed ID: 28266937
[TBL] [Abstract][Full Text] [Related]
15. Effect of Adjunctive Dexmedetomidine in the Treatment of Alcohol Withdrawal Compared to Benzodiazepine Symptom-Triggered Therapy in Critically Ill Patients: The EvADE Study.
Collier TE; Farrell LB; Killian AD; Kataria VK
J Pharm Pract; 2022 Jun; 35(3):356-362. PubMed ID: 33297835
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for alcohol withdrawal-related hospital transfer in a correctional setting.
Muradian IK; Qureshi N; Singh J; Lin CH; Henderson SO
Alcohol; 2023 Sep; 111():33-37. PubMed ID: 37119833
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a modified MINDS-based protocol for management of alcohol withdrawal syndrome on an inpatient medical service.
Krcmarik KM; Hulley BJ; Huang J; Juang D; Cadman P; Urbiztondo C; Vo C; Vargas J; Motarjemi R; Moinizandi T; Kwan B
Pharmacotherapy; 2023 Dec; 43(12):1297-1306. PubMed ID: 37475509
[TBL] [Abstract][Full Text] [Related]
18. A Comparison of Injectable Diazepam and Lorazepam in the Goal-Directed Management of Severe Alcohol Withdrawal.
Brickel KH; Hodge EK; Zavgorodnyaya D; Schroeder JM; Brown LH; Daley MJ
Ann Pharmacother; 2024 May; 58(5):453-460. PubMed ID: 37606361
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital for Acute Alcohol Withdrawal Management in Surgical Trauma Patients-A Retrospective Comparison Study.
Nejad S; Nisavic M; Larentzakis A; Dijkink S; Chang Y; Levine AR; de Moya M; Velmahos G
Psychosomatics; 2020; 61(4):327-335. PubMed ID: 32199629
[TBL] [Abstract][Full Text] [Related]
20. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
